Pfizer Admits: Vaccine Protects Against Disease, But Important Question Remains Unanswered



[ad_1]

Many have begun to see the light at the end of the tunnel, now that various coronary vaccines are about to be approved and thus can be distributed to different countries. The United Kingdom and the United States have already approved the Pfizer vaccine, and it is also one of the vaccines that Norway and the Scandinavian countries will also have access to.

Vaccination is expected to start in early 2021, but a Danish professor prefers cold water over the years to anyone who believes life will immediately return to normal.

Not investigated this

Jens Lundgren, who is a professor of infectious disease medicine at the University of Copenhagen, has spoken to Danish TV 2 and says that the Danes cannot change their behavior, even though they have received the Pfizer vaccine. In preparing the vaccine, Pfizer and BioNTech have not investigated whether it protects against the infection itself, which in principle should be normal practice.

– Danes don’t have to immediately keep their distance, wear a bandage and spread their hands, even if they have been vaccinated, Lundgren tells Danish TV 2.

Bent Høie has revealed what the order of priority will look like in Norway:

Like Norway, the Danes have decided that the elderly and vulnerable should be vaccinated first, and Lundgren’s call is very clear.

– First of all, we cannot be sure that the vaccine protects everyone. And as long as there is high infection pressure in Denmark, it will be wise not to expose yourself to infection, says the professor.

Very high infection rates

The Danes are currently in a very serious period. For the third day in a row, the country recorded more than 3,000 new corona infections, and Saturday was a new record.

The Statens Serum Institut reports 3,552 new cases of infection. The number is the highest so far in the pandemic. But keep in mind that the period includes 28 hours and a record number of tests: 118,130. The number of patients admitted with covid-19 has increased from 10 to 371. At the same time, another eight deaths related to coronary heart disease are reported.

The proportion of positive samples among those that have been analyzed is 3.0 and is the highest that has been recorded so far. In the last two weeks, Denmark has registered 462 infected per 100,000 inhabitants.


95 percent protection

Preliminary testing of the Pfizer vaccine shows that it provides protection against COVID-19 in 95 percent of cases. This is also one of several vaccines that may be approved in Norway by the end of the year, as it is currently for EU approval and therefore also for use in Norway.

Pfizer Denmark CEO Anne Bloch Thomsen says the company will continue to collect efficiency and safety data for another two years. He also says that they are still investigating whether vaccinated people can infect other people or not.

The vaccine should be taken in two doses, three weeks apart. It also stands out because it should be stored at minus 70 degrees and only lasts for five days in the refrigerator. According to NTB, it will cost around 180 crowns per dose, but all Norwegians who want to get vaccinated do not have to pay out of pocket.

[ad_2]